辅助生殖技术中附加项目使用的道德正当性:专家的观点与经验
本研究对31名辅助生殖技术专业人员进行定性访谈分析,探讨医生在决定是否提供附加项目时考虑的因素。结果显示,医生会权衡获益与伤害的可能性、患者心理需求与偏好以及组织期望,其中患者偏好、心理因素和低伤害风险似乎比提高活产率或创新愿望更具驱动力。结论提示附加项目与创新未必紧密关联,可考虑监管改革或明确未经验证附加项目与补充替代医学的相似性。
要点
- 医生决定是否提供附加项目时,会考虑获益与伤害可能性、患者心理需求与偏好及组织期望。
- 患者偏好、心理因素和低伤害风险似乎比提高活产率或创新愿望更具驱动力。
- 作者认为不能想当然地认为附加项目与创新紧密关联,可考虑监管改革或明确未经验证附加项目的定位。
核心结论
- 这些发现提示不能想当然地认为附加项目与创新紧密关联。
- 一种可能的应对是监管改革,例如仅允许在正式科学评估背景下使用「未经验证」的附加项目。
- 另一种可能是明确未接受正式评估的附加项目与其他缺乏明确证据基础的疗法(如补充和替代医学)的相似性大于与传统医疗实践的相似性。
- 与附加项目相关的实践可能还需要关注公司的责任以及适用于消费品和服务提供者的标准。
研究设计与样本
- 对31名辅助生殖技术专业人员的访谈进行定性分析,聚焦其对附加项目的观点与经验,包括医生决定使用附加项目时考虑的因素。
主要发现
- 参与者报告,在特定情况下论证使用某一附加项目时,会考虑一系列因素,包括获益与伤害的可能性、患者感知的心理需求与偏好以及组织期望。
- 患者偏好、心理因素和低伤害风险似乎比提高活产率或创新愿望是更强的动机。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RESEARCH QUESTION: What factors do assisted reproductive terchnology (ART) providers take into account when they make decisions about offering 'add-ons'? DESIGN: A qualitative analysis of interviews with 31 ART professionals, focusing on their views and experiences in relation to add-ons, including the factors that are considered when doctors make decisions about their use. RESULTS: The participants reported that a range of considerations are taken into account when it comes to justifying the use of a particular add-on in a given circumstance, including the likelihood of benefit and harm, patients' perceived psychological needs and preferences, and organizational expectations. Importantly, patient preferences, psychological factors and low risk of harm appear to be stronger motivations than increasing the likelihood of a live birth or the desire to innovate. CONCLUSIONS: These findings suggest that it cannot be taken for granted that add-ons and innovation are closely linked. One possible response to this would be regulatory reform; for example, only allowing 'unproven' add-ons to be used in the context of formal scientific evaluation. Alternatively, it could be made clear that add-ons that are not undergoing formal evaluation have more in common with other therapies lacking a clear evidence base, such as complementary and alternative medicines, than with conventional medical practice. Practices in relation to add-ons may also require a focus on the responsibilities of corporations, and the standards applying to purveyors of consumer goods and services.
引用
- Gallagher S, Kerridge I, Newson A, et al. Moral justification for the use of 'add-ons' in assisted reproductive technology: experts' views and experiences. Reprod Biomed Online. 2023. PMID: 38185024. doi:10.1016/j.rbmo.2023.103637
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。